semaglutide fda approval for weight loss Kids approved drugs! The FDA has approved a

Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, doubleblind, doubledummy, placebocontrolled, phase 3a trial

The key question is whether the COA documentation supports the claim

4,107 These findings are further supported by RCTs in older adults demonstrating that dietary weight loss alone leads to a decline in BMD, while control groups maintain stable bone mass

As a result, they destroy the cells

A PCOS-focused review (not endometriosis-specific) highlights these class effects and related cautions like gastroparesis risk/worseningreinforcing that slowed motility isnt rare or trivial